In 2016, more than 42,000 people in the United States died from opioid overdoses. A host of complex social, structural and drug-related factors have contributed to the overdose epidemic, but one of the primary factors in recent years is the synthetic opioid fentanyl. Officials are focused on a variety of efforts to address the opioid epidemic and overdose crisis, including finding solutions to help prevent new addictions, increasing access to treatment, trying to halt the supply of illicit substances. But to a far lesser extent, they include harm reduction – or strategies aimed at protecting the health and saving the lives of those people who are actively using drugs. In this episode, we talk about harm reduction, and we take a look at a recent study that has the potential to inform an innovative public health approach to the overdose epidemic.
A Federal Agenda for Opportunity Youth
Will Biden's Infrastructure Plan Address Years of Inequity?
How Pediatricians Are Addressing School Absenteeism
COVID Housing Challenges for Black Women Survivors of Intimate Partner Violence
Bloomberg Fellows Spotlight: Katherine Chon
Bloomberg Fellows Spotlight: Marissa Silverberg
Bloomberg Fellows Spotlight: Lorne Carroll
Bloomberg Fellows Spotlight: Ashley Hickson
Bloomberg Fellows Spotlight: Melissa Box
Bloomberg Fellows Spotlight: Della Wright
Bloomberg Fellows Spotlight: Janice Miller
Bloomberg Fellows Spotlight: Jullian Tse
Bloomberg Fellows Spotlight: JR Westerberg
Bloomberg Fellows Spotlight: Amelia Hulbert
Bloomberg Fellows Spotlight: Paige Volpenhein
Bloomberg Fellows Spotlight: Katherine Thomsen
Bloomberg Fellows Spotlight: Kat Humphries
Bloomberg Fellows Spotlight: Mary Odell
Bloomberg Fellows Spotlight: Thaddeus Pham
Bloomberg Fellows Spotlight: Amanda Capitummino
Create your
podcast in
minutes
It is Free
Masters in Business
Odd Lots
Bloomberg Surveillance
Bloomberg Businessweek
Prognosis: Losing it